IOVA Iovance Biotherapeutics, Inc.
Healthcare$4.10-0.24%ClosedMarket Cap: $1.47B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$2.00
Target (Median)
$2.00
Target Range
$2.00 - $2.00
Upside from current price: -51.2%
Rating Distribution
2 Strong Buy6 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-05 | UBS | maintain | Neutral | Neutral |
| 2026-03-03 | Citizens | upgrade | Market Outperform | Market Perform |
| 2026-02-25 | Barclays | maintain | Overweight | Overweight |
| 2025-12-17 | Barclays | maintain | Overweight | Overweight |
| 2025-11-06 | Chardan Capital | maintain | Buy | Buy |
| 2025-10-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-08 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-08 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.31 | $493.7M | 6 |
| Sun Dec 31 | $0.00 | $719.1M | 5 |
| Mon Dec 31 | $0.22 | $952.0M | 1 |
| Tue Dec 31 | $0.43 | $1.18B | 1 |